Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseOxidative stress and Parkinson's diseaseActivin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's diseaseLithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model.Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's DiseaseMajor Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.Electroacupuncture Alleviates Depressive-Like Symptoms and Modulates BDNF Signaling in 6-Hydroxydopamine RatsAldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.Estrogens, Neuroinflammation, and Neurodegeneration.Vagal neurocircuitry and its influence on gastric motilityOverview of mouse models of Parkinson's disease.Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model.Evidence for cross-hemispheric preconditioning in experimental Parkinson's disease.Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse.Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease.CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study
P2860
Q26750370-1C854757-3A76-4510-853E-AB70681F3069Q26798897-EAF59AC9-4971-42A5-BD0A-B39D3C24EBBEQ27309140-F7494AB0-A961-4A3E-A631-4A08454F28DFQ34625750-D591CB1E-E5A7-44E7-8396-8C56684B5F3FQ35147682-EE04832F-24F4-4B88-BAF6-F92D16687966Q35623461-AA74C1D9-60E3-48A6-A7AB-415641ADD095Q35829484-B4DE5FA3-01D6-4985-8195-4D514D703417Q36088639-099DD988-F1E6-4558-B144-3908670B963CQ36275740-8CB84362-D2E8-4F30-942E-341CAE07A8B8Q36534782-4A1DDF62-D029-469E-8CC1-06238A4BBD8AQ37156957-EE31B4E1-54D4-4EE6-9BA5-C9CB740A1BB1Q38258298-30C3AB63-3D98-441D-9856-D76CCD817A03Q38731068-6C00ED53-C4FD-402C-96AF-8976EC25E81EQ38838452-994BF644-6DC0-4C5F-84FB-946457B34711Q38850684-1B00C8C0-297C-440E-B228-77AAFD2A134FQ42473489-D6547651-9B96-4ECA-B3B0-9300B372F5D0Q47275717-ADDFC819-FF22-4A55-8F27-8D1EEB553575Q47441179-82A38C31-37EA-4702-9EEB-583CE8F88812Q47907310-5F23717B-F15D-4BA8-9956-42ABBDE923FBQ48152730-B10E6952-5A9B-4257-9E98-6741F1E92B9AQ48274786-524EA2A8-F051-4DF7-A402-EA924B5F16F6Q48670602-8A8B06E3-4AED-48C5-95E0-5F88E8B562A2Q52148873-315DB3F3-D860-45BA-94D2-E3DA4D520A4FQ58712148-CDCF0E39-3695-4AB9-9AC9-E287C9B12875
P2860
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Time course of dopamine neuron ...... model of Parkinson's disease.
@en
Time course of dopamine neuron ...... model of Parkinson's disease.
@nl
type
label
Time course of dopamine neuron ...... model of Parkinson's disease.
@en
Time course of dopamine neuron ...... model of Parkinson's disease.
@nl
prefLabel
Time course of dopamine neuron ...... model of Parkinson's disease.
@en
Time course of dopamine neuron ...... model of Parkinson's disease.
@nl
P2860
P921
P356
P1476
Time course of dopamine neuron ...... e model of Parkinson's disease
@en
P2093
Simon R W Stott
P2860
P304
P356
10.1111/EJN.12459
P407
P577
2013-12-26T00:00:00Z